Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
GHK-Cu also modulates gene expression through mechanisms that remain incompletely characterized but involve broad transcriptomic changes affecting over 4,000 human genes as identified through Connectivity Map (CMAP) analysis
The related Athira compound fosgonimeton failed its Phase 2 Alzheimer's trial (LIFT-AD) in 2023 for efficacy, and Athira discontinued development
The right choice often comes down to your goals: rapid release suits those seeking faster absorption and upper digestive system support, while delayed release is well-suited for more ongoing support for gut health and general wellness
R., Fritsche, A., Gribble, F., Grill, H
Disclose to your physician: All prescription medications, over-the-counter supplements, weight loss products, stimulants, thyroid medications, and any other peptides or hormones before starting AOD-9604 therapy
BPC-157 + TB-500 Blend Vial A 20 mg vial covers a 4-week cycle at either dose
US$ 28.53
US$ 28.76
US$ 28.23
US$ 20.56
US$ 20.69
US$ 22.65
US$ 21.96
US$ 28.79
US$ 20.95
US$ 28.78
US$ 29.17
US$ 26.21
US$ 24.93
